spasticity stroke spasticity upper limb
Conditions
Interventions
We will treat the subjects with 240 units of onabotulinumtoxinA (BOTOX) injected into muscles of the affected upper limb using EMG guide.
We then perform robotics rehabilitation with Hybrid Assisted
robotics rehabilitation
Sponsors
Fujita Koji
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Those who can understand the significance and the risk of this study Those with upper limb spasticity after stroke with its onset more than 1 year prior to the study Those who have had no relapse of stroke after the initial onset Those who have no apparent decline in cognitive function (HDSR>23) Those who have no apparent deppressive symptoms Those who have no major physical and mental disorders
Exclusion criteria
Exclusion criteria: Those with pregnancy Those with major systemic diseases Those with progressive central nervous system diseases (such as brain tumor) Those with contractures of the elbow joint or with spasticity of modified Ashworth scale being 4
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| changes in active ROM of the elbow joint treated (more than 15 degrees are regarded as significant chang) | — |
Secondary
| Measure | Time frame |
|---|---|
| Fugel-Myer Assessment(FMA), Brunnstrom stage, Visual ,Analogue Scale, changes in sensory impairment (proprioception, kinesthesia) | — |
Contacts
Public ContactKoji Fujita
Tokushima University Hospital
Outcome results
None listed